Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

Paper Submission

Views	Downloads

Relative Articles
Molecular Structure and Crystal Packing of n-Type Semiconducting Material 3′,3′-(1,4-Phenylene)bis{2′-(4′′-trifluoromethyl)phenyl}acrylonitrile
Oximes in organophosphorus poisoning
Antibacterial Activity of Salicylanilide 4-(Trifluoromethyl)-benzoates
Fluorine in medicine
Oximes of Seven-Membered Heterocyclic Compounds Containing One Heteroatom
UV Spectral Properties of Benzophenone. Influence of Solvents and Substituents
Reaction of Nitrilimines and Nitrile Oxides with Hydrazines, Hydrazones and Oximes
Pyridinium 4-(trifluoromethyl)benzenesulfonate
Tris[3,5-bis(trifluoromethyl)phenyl]phosphine oxide
(Z)-N′-Hydroxy-4-(trifluoromethyl)benzimidamide
More...

International Journal of Molecular Sciences 2011

Antibacterial Activity of New Dibenzoxepinone Oximes with Fluorine and Trifluoromethyl Group Substituents

DOI: 10.3390/ijms12106432

Carmen Limban,Mariana Carmen Chifiriuc

Keywords: dibenz[b,e]oxepin, methanone derivatives, antibacterial activity, gram-positive, gram-negative

Full-Text Cite this paper Add to My Lib

Abstract:

In this paper we present the antimicrobial activity of some newly synthesized dibenz[ b, e]oxepin derivatives bearing the oximino moiety, and fluorine (F) and trifluoromethyl (CF 3) group substituents. The chemical structure and purity of the new compounds were assessed by using elemental analysis, NMR and FTIR spectroscopy. The new compounds were screened for their antibacterial activity towards Gram-positive and Gram-negative strains, by qualitative and quantitative assays. Our results demonstrated that the CF 3 and F disubstituted compounds could be considered for the further development of novel antimicrobial drugs.

References

[1]	Bloom, BM; Tretter, JR. Dibenzo[b,e]oxepin-11-one. Belg Patent 641498, 18 June 1964.
[2]	Stach, K; Bickelkaupt, F. Beitr？ge zur Entwicklung psychotroperStoffe, 2. Mitt.: Basisch substituierte Dibenzo-oxepin-, Dibenzo-thiepin- und Dibenzo-cycloocten-Derivate. Mon. Chem 1962, 93, 896–904.
[3]	Stach, K. Dibenzoxepine and dibenzothiepine derivatives. US Patent 3,438,981, 15 April 1969.
[4]	Ueno, K; Kubo, S; Yoshioka, T; Tagawa, H; Shimada, S; Kojima, H; Tsukada, H; Tsubolawa, M. Dibenzoxepine derivatives. Jap Patent 8000377, 5 January 1980.
[5]	Ueno, K; Kubo, S; Tagawa, H; Yoshioka, T; Teukada, W; Tsubokawa, M; Kojima, H; Kasahara, A. 6,11-Dihydro-11-oxodibenz[b,e]oxepinacetic acids with potent antiinflammatory activity. J. Med. Chem 1976, 19, 941–946.
[6]	Hoehn, H. Imidazole derivatives of 6,11-dihydrodibenz[b,e]oxepins and 6,11-dihydrodibenz[b,e]thiepines. US Patent 4,169,205, 25 September 1979.
[7]	Lin, J; Liu, S; Sun, B; Niu, S; Li, E; Liu, X; Che, Y. Polyketides from the ascomycete fungus Leptosphaeria sp. J. Nat. Prod 2010, 73, 905–910.
[8]	Saeed, A; Shaheen, U; Hameed, A; Haider Naqvi, SZ. Synthesis, characterization and antimicrobial activity of some new 1-(fluorobenzoyl)-3-(fluorophenyl) thioureas. J. Fluor. Chem 2009, 130, 1028–1034.
[9]	Smart, BE. Fluorine substituent effects (on bioactivity). J. Fluor. Chem 2001, 109, 3–11.
[10]	Filler, R; Saha, R. Fluorine in medicinal chemistry: A century of progress and a 60-year retrospective of selected highlights. Future Med. Chem 2009, 1, 777–791.
[11]	Limban, C; Missir, AV; Chiri？？, IC; Caproiu, MT; Draghici, C; Ni？ulescu, GM. Novel dibenz[b,e]oxepins derivatives. Rev. Chim. Buchar 2009, 60, 1313–1317.
[12]	Olar, R; Badea, M; Cristurean, E; Lazar, V; Cernat, R; Balotescu, MC. Thermal behavior; spectroscopic and biological characterization of Co(II); Zn(II); Pd(II) and Pt(II) complexes with N,N-dimethylbiguanide. J. Therm. Anal. Calorim 2005, 80, 451–455.
[13]	Lazar, V; Balotescu, MC; Moldovan, L; Vasilescu, G; Petrache, LM; Bulai, D; Cernat, R. Comparative evaluation of qualitative and quantitative methods used in the study of antibacterial and antifungal activity of hydroalcoholic vegetal extracts. Roum. Biotechnol. Lett 2005, 10, 2225–2232.
[14]	Balotescu, MC; Oprea, E; Petrache, LM; Bleotu, C; Lazar, V. Antibacterial; antifungal and cytotoxic activity of Salvia officinalis essential oil and tinctures. Roum. Biotechnol. Lett 2005, 10, 2481–2481.
[15]	CLSI. Performance Standard for Antimicrobial Susceptibility Testing; Twenty-First Information Supplement. CLSI document M100-S21; CLSI: Wayne, PA, USA, 2011.
[16]	CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard. CLSI document M07-A8; CLSI: Wayne, PA, USA, 2009.
[17]	Balotescu, MC; Limban, C; Missir, AV; Chirita, IC; Nitulescu, GM. The synthesis and biological activities of some new 2-(4-methoxy-phenoxymethyl)benzoic acid thioureides. Rev. Chim. Buchar 2007, 58, 1064–1068.

Full-Text